NKTR vs. JPM
NKTR (Nektar Therapeutics) and JPM (JPMorgan Chase & Co.) are both stocks. NKTR operates in Biotechnology (Healthcare), while JPM operates in Banks - Diversified (Financial Services). Over the past 10 years, NKTR returned -12.14%/yr vs 21.80%/yr for JPM. Their 0.27 correlation means their historical movements had little consistent relationship.
Performance
NKTR vs. JPM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NKTR achieves a 67.15% return, which is significantly higher than JPM's 10.73% return. Over the past 10 years, NKTR has underperformed JPM with an annualized return of -12.14%, while JPM has yielded a comparatively higher 21.80% annualized return.
NKTR
- 1D
- -1.09%
- 1M
- -0.52%
- 6M
- 89.31%
- YTD
- 67.15%
- 1Y
- 207.80%
- 3Y*
- 108.39%
- 5Y*
- -21.49%
- 10Y*
- -12.14%
- ALL TIME*
- 0.66%
JPM
- 1D
- 0.27%
- 1M
- 5.65%
- 6M
- 16.11%
- YTD
- 10.73%
- 1Y
- 23.90%
- 3Y*
- 33.72%
- 5Y*
- 21.31%
- 10Y*
- 21.80%
- ALL TIME*
- 12.44%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.69B | $3.19B | $3.04B | |
| $53.73M | $57.41M | $67.60M |
NKTR vs. JPM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NKTR Nektar Therapeutics | 67.15% | 203.08% | 64.60% | -75.00% | -83.27% | -20.53% | -21.26% | -34.32% | -44.96% | 386.72% |
JPM JPMorgan Chase & Co. | 10.73% | 37.27% | 44.29% | 30.63% | -12.64% | 27.75% | -5.53% | 47.26% | -6.62% | 26.76% |
Correlation
The correlation between NKTR and JPM is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since May 3, 1994 | 0.27 |
Fundamentals
NKTR:
$1.38B
JPM:
$942.62B
NKTR:
-$8.02
JPM:
$23.29
NKTR:
25.03
JPM:
3.30
NKTR:
3.03
JPM:
2.78
NKTR:
$55.63M
JPM:
$297.63B
NKTR:
$44.58M
JPM:
$186.33B
NKTR:
-$121.05M
JPM:
$90.84B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NKTR vs. JPM — Risk / Return Rank
NKTR
JPM
NKTR vs. JPM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NKTR | JPM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.59 | ||
| Sortino ratioReturn per unit of downside risk | +2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.17 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 4.89 | 1.36 | +3.52 |
| Martin ratioReturn relative to average drawdown | 9.90 | 3.24 | +6.65 |
Loading charts...
Drawdowns
NKTR vs. JPM - Drawdown Comparison
The maximum NKTR drawdown since its inception was -99.61%, which is greater than JPM's maximum drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for NKTR and JPM.
Loading charts...
Drawdown Indicators
| NKTR | JPM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.61% | -76.16% | -23.45% |
Max Drawdown (1Y)Largest decline over 1 year | -46.54% | -15.47% | -31.07% |
Max Drawdown (3Y)Largest decline over 3 years | -73.20% | -24.42% | -48.78% |
Max Drawdown (5Y)Largest decline over 5 years | -97.76% | -38.77% | -58.99% |
Max Drawdown (10Y)Largest decline over 10 years | -99.61% | -43.63% | -55.98% |
Current DrawdownCurrent decline from peak | -95.66% | -1.54% | -94.12% |
Average DrawdownAverage peak-to-trough decline | -68.44% | -17.56% | -50.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.94% | 6.51% | +16.43% |
Volatility
NKTR vs. JPM - Volatility Comparison
Nektar Therapeutics (NKTR) has a higher volatility of 15.44% compared to JPMorgan Chase & Co. (JPM) at 6.60%. This indicates that NKTR's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NKTR | JPM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.44% | 6.60% | +8.84% |
Volatility (6M)Calculated over the trailing 6-month period | 60.68% | 16.70% | +43.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.80% | 22.50% | +67.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.06% | 24.46% | +97.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.22% | 27.33% | +69.89% |
Dividends
NKTR vs. JPM - Dividend Comparison
NKTR has not paid dividends to shareholders, while JPM's dividend yield for the trailing twelve months is around 1.71%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JPM JPMorgan Chase & Co. | 1.71% | 1.72% | 1.92% | 2.38% | 2.98% | 2.34% | 2.83% | 2.37% | 2.54% | 1.91% | 2.13% | 2.54% |
NKTR Nektar Therapeutics | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NKTR vs. JPM - Financials Comparison
This section allows you to compare key financial metrics between Nektar Therapeutics and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NKTR and JPM have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NKTR has higher volatility (15.44%) compared to JPM (6.60%). In terms of maximum drawdown, NKTR dropped -99.61% vs JPM's -76.16%.
NKTR currently has the higher Sharpe Ratio (2.53 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NKTR and JPM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer